Dragon Pharma DSIP β Sleep and Recovery Peptide
DSIP 10 mg by Dragon Pharma is a research peptide commonly discussed in protocols related to sleep quality, recovery, and stress regulation. Short for Delta Sleep-Inducing Peptide, DSIP has attracted long-term interest in peptide research because of its association with deep sleep patterns, circadian rhythm support, and overall recovery capacity.
For athletes, bodybuilders, and high-stress users, sleep quality can directly affect recovery, hormonal balance, focus, and training output. For users looking to buy DSIP by Dragon Pharma, product quality, sterile handling, and consistent sourcing are all important when evaluating a peptide for research purposes.
DSIP Composition
DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide composed of 9 amino acids. It has been investigated for its potential role in sleep regulation, stress response, and neuroendocrine balance.
Unlike traditional sleep aids that work through sedative action, DSIP is generally studied for its possible influence on natural sleep architecture and deeper stages of restorative sleep.
Sleep, Recovery, and Performance Support
In performance-focused communities, DSIP is most often researched for its relationship to sleep quality and overnight recovery. Since recovery processes are closely tied to deep sleep, peptides associated with sleep architecture have become increasingly relevant in physique and training-focused protocols.
- Sleep quality support: researched for deeper and more restorative sleep patterns
- Recovery support: often explored in protocols centered on physical recovery from hard training
- Stress regulation: commonly discussed in relation to cortisol balance and recovery under pressure
- Circadian rhythm support: investigated in users with irregular schedules or disrupted sleep timing
- Non-sedative interest: often considered by users looking beyond conventional sleep compounds
For more background on the peptide's research history, you can refer to this PubMed study on DSIP and sleep regulation.
Research Background
DSIP has been studied in relation to sleep regulation, stress adaptation, and neuroendocrine activity. Research interest has included its potential role in delta sleep support, HPA-axis modulation, and circadian function.
Its profile has also made it relevant in recovery-focused discussions among athletes and bodybuilders who place a high value on deep sleep as a foundation for muscle repair, nervous system recovery, and daytime performance.
Dosage (Men)
Note: DSIP is intended for research purposes only. The following reflects common protocol patterns and provided context rather than medical advice.
DSIP is commonly researched in low-dose evening protocols, often administered 30-60 minutes before sleep. Example protocol ranges may include:
- Standard Protocol: 100-300 mcg per night for 5-7 days, then reassess
- Loading Protocol: 300-500 mcg nightly for the first several days, followed by lower maintenance use
- Intermittent Protocol: 2-3 times weekly after the initial phase, depending on response
The 10 mg vial is commonly reconstituted with 2 mL of bacteriostatic water, producing a concentration of 5 mg/mL. At that concentration, a 200 mcg dose equals 0.04 mL, or 4 units on a U-100 insulin syringe.
Dosage (Women)
Female research protocols often use slightly lower nightly amounts, frequently in the range of 50-200 mcg, depending on protocol design and response. Lower maintenance use a few times per week is also common in anecdotal research discussions.
Active Life
DSIP is known for having a short circulating half-life, but research discussions often describe effects that may extend beyond the immediate dosing window. This is one reason intermittent use is sometimes referenced in DSIP-related protocols.
DSIP Side Effects
DSIP is generally discussed as well tolerated in research settings. When side effects are mentioned, they are often mild and may include vivid dreams, temporary drowsiness, headache, or minor injection-site irritation.
Because DSIP is frequently used in evening protocols, accurate timing and conservative dosing are commonly emphasized when evaluating tolerance.
DSIP Contraindications/Precautionary Measures
DSIP should not be used by pregnant or nursing women. Individuals with significant psychiatric or neurological conditions should use caution when considering compounds that may affect sleep or central nervous system regulation. Because DSIP may overlap with other sleep-related or CNS-active compounds, careful protocol planning is advised. Always use sterile technique and keep out of reach of children.
Overdosage
Excessive dosing may increase the risk of prolonged drowsiness, vivid dreaming, temporary disruption of normal sleep patterns, or headache. If accidental overuse occurs, discontinue use and seek medical advice.
DSIP Stack/Cycle
DSIP is often researched alongside other peptides connected to sleep, circadian support, or stress management. Common combinations include:
- Epitalon β frequently explored in sleep and circadian rhythm-focused research stacks
- Melanotan 2 10 mg β sometimes discussed in broader recovery and sleep-related protocols
- Selank β often researched in protocols involving stress management, calm focus, and evening recovery support
These combinations are typically explored by users interested in sleep quality, recovery, and improved resilience during demanding training periods or irregular schedules.
Package Presentation
Dragon Pharma presents DSIP in a sterile 2 mL vial containing 10 mg of lyophilized powder. The freeze-dried format helps preserve stability before reconstitution and supports accurate dose preparation.
Storage
Store the lyophilized vial in a cool, dry place away from direct light and moisture, ideally at 2-8Β°C. After reconstitution with bacteriostatic water, keep refrigerated and use within 2-3 weeks for best stability. Do not freeze.
DSIP Referrers
This product is intended for laboratory research and analytical purposes only. Not for human consumption. Always verify the legality of this compound in your jurisdiction before purchase.